Emerging targeted therapies in oral oncology: Focus on EGFR inhibition

Emerging targeted therapies in oral oncology: Focus on EGFR inhibition

This comprehensive study explored the role of epidermal growth factor receptor (EGFR)-targeted therapies in oral cancer, focusing on emerging strategies, challenges, and future directions. The EGFR signalling pathway plays a critical role in the development and progression of oral cancer, making it...

Full description

Saved in:
Bibliographic Details
Main Authors: Vishnu Priya Veeraraghavan, Shikhar Daniel, Arun Kumar Dasari, Kaladhar Reddy Aileni, Chaitra patil, Santosh R. Patil
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:Oral Oncology Reports
Subjects:
Epidermal growth factor receptor (EGFR)
Oral cancer
Targeted therapy
Tyrosine kinase inhibitors (TKIs)
Monoclonal antibodies (mAbs)
Combination therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2772906024004382
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2772906024004382

Similar Items